Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Christian Stensborg Holding ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.1% 2.8% 2.3% 3.7% 4.9% 2.9% 6.7% 6.7%   Credit score (0-100)   58 60 64 50 44 57 36 36   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,891 1,714 1,891 1,843 1,830 2,240 0.0 0.0   EBITDA   1,234 1,152 1,202 1,224 879 1,188 0.0 0.0   EBIT   1,133 1,043 1,093 1,112 766 1,069 0.0 0.0   Pre-tax profit (PTP)   290.9 114.6 393.5 256.2 -105.1 327.7 0.0 0.0   Net earnings   231.4 184.9 303.0 196.8 -86.5 251.7 0.0 0.0   Pre-tax profit without non-rec. items   291 115 393 256 -105 328 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   212 211 168 140 94.1 97.8 0.0 0.0   Shareholders equity total   830 907 1,099 1,183 982 1,116 944 944   Interest-bearing liabilities   853 824 201 182 135 1.9 0.0 0.0   Balance sheet total (assets)   1,946 1,988 1,889 1,719 1,535 1,729 944 944   Net Debt   789 615 171 152 105 -119 -189 -189     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,891 1,714 1,891 1,843 1,830 2,240 0.0 0.0   Gross profit growth   -1.4% -9.4% 10.3% -2.5% -0.7% 22.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,946 1,988 1,889 1,719 1,535 1,729 944 944   Balance sheet change%   -20.3% 2.1% -5.0% -9.0% -10.7% 12.7% -45.4% 0.0%   Added value   1,233.8 1,151.7 1,202.2 1,224.5 878.9 1,187.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -439 -177 -219 -208 -225 -183 -98 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   59.9% 60.9% 57.8% 60.3% 41.9% 47.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.6% 9.1% 23.3% 17.1% -1.8% 24.1% 0.0% 0.0%   ROI %   18.5% 10.1% 28.1% 20.6% -2.1% 29.6% 0.0% 0.0%   ROE %   30.2% 21.3% 30.2% 17.3% -8.0% 24.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   42.7% 45.7% 58.6% 69.0% 64.1% 66.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   63.9% 53.4% 14.2% 12.4% 11.9% -10.0% 0.0% 0.0%   Gearing %   102.8% 90.9% 18.3% 15.4% 13.7% 0.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.5% 7.7% 11.5% 27.4% 47.5% 96.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.7 1.2 2.0 1.6 2.8 0.0 0.0   Current Ratio   0.6 0.7 1.2 2.0 1.6 2.4 0.0 0.0   Cash and cash equivalent   64.4 208.9 30.0 30.0 30.0 120.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -398.9 -291.6 100.5 334.9 228.1 501.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,234 1,152 1,202 1,224 879 1,188 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,234 1,152 1,202 1,224 879 1,188 0 0   EBIT / employee   1,133 1,043 1,093 1,112 766 1,069 0 0   Net earnings / employee   231 185 303 197 -87 252 0 0